XML 54 R43.htm IDEA: XBRL DOCUMENT v3.23.2
Segment Reporting (Tables)
6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
Schedule of Segment Performance The following is a summary of segment performance:
(in thousands)For the Three Months Ended June 30,
CAGWaterLPDOtherConsolidated Total
2023
Revenue$866,652 $43,029 $29,911 $4,038 $943,630 
Income from operations$275,509 $19,820 $1,951 $(1,136)$296,144 
Interest expense, net(10,215)
Income before provision for income taxes285,929 
Provision for income taxes61,693 
Net income attributable to IDEXX Laboratories, Inc. stockholders$224,236 
2022
Revenue$784,087 $39,195 $29,889 $7,375 $860,546 
Income from operations$156,526 $17,920 $3,230 $1,390 $179,066 
Interest expense, net(7,983)
Income before provision for income taxes171,083 
Provision for income taxes39,104 
Net income attributable to IDEXX Laboratories, Inc. stockholders$131,979 
(in thousands)For the Six Months Ended June 30,
CAGWaterLPDOtherConsolidated Total
2023
Revenue$1,693,931 $81,912 $59,119 $8,863 $1,843,825 
Income from operations$537,259 $36,791 $3,259 $(766)$576,543 
Interest expense, net(22,926)
Income before provision for income taxes553,617 
Provision for income taxes115,327 
Net income attributable to IDEXX Laboratories, Inc. stockholders$438,290 
2022
Revenue$1,545,271 $75,566 $60,759 $15,499 $1,697,095 
Income from operations$379,651 $34,574 $9,967 $3,218 $427,410 
Interest expense, net(14,836)
Income before provision for income taxes412,574 
Provision for income taxes86,630 
Net income attributable to IDEXX Laboratories, Inc. stockholders$325,944